Trials / Completed
CompletedNCT06140758
Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model
Evaluation of the Anticaries Efficacy of Various Dentifrice Formulations Using an In-situ Model
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to compare the remineralization and demineralization inhibition potential of early subsurface carious lesions in enamel in situ after rinsing with six different aqueous slurries of toothpaste formulations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate) Dentifrice | Each subject will use this product during one of the six treatment periods in the crossover study design. |
| DRUG | Colgate 1450 ppm Fluoride (1.16% sodium monofluorophosphate)Dentifrice | Each subject will use this product during one of the six treatment periods in the crossover study design. |
| DRUG | Toms of Maine 0 ppm Fluoride Dentifrice | Each subject will use this product during one of the six treatment periods in the crossover study design. |
| DRUG | Colgate 1450 ppm Fluoride (1.1% sodium monofluorophosphate) Dentifrice | Each subject will use this product during one of the six treatment periods in the crossover study design. |
| DRUG | 1500 ppm MFP/CaCO3 1.16% sodium monofluorophosphate) Dentifrice | Each subject will use this product during one of the six treatment periods in the crossover study design. |
| DRUG | 1100 ppm (0.454% Stannous fluoride) Dentifrice | Each subject will use this product during one of the six treatment periods in the crossover study design. |
Timeline
- Start date
- 2023-07-31
- Primary completion
- 2023-12-11
- Completion
- 2023-12-11
- First posted
- 2023-11-20
- Last updated
- 2024-02-29
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06140758. Inclusion in this directory is not an endorsement.